✉news HealthMedicine first seen 1 d ago, last 1 d ago, peak #8
Disc Medicine to Present APOLLO Phase 3 Results for Bitopertin
Original: Disc Medicine to Host Webcast on APOLLO Phase 3 Topline Results for Bitopertin in EPP
Disc Medicine will host a webcast to announce topline results from its APOLLO Phase 3 clinical trial of bitopertin in erythropoietic protoporphyria (EPP), a rare light-sensitive blood disorder. The announcement of the upcoming results presentation has drawn attention from investors and the biotech community awaiting data on the drug's efficacy.
Why now: Investors and biotech watchers are anticipating the Phase 3 trial results, which could determine the drug's future and the company's prospects.
Disc MedicinebitopertinAPOLLO Phase 3 trialerythropoietic protoporphyria
Evidence
- Disc Medicine to Host Webcast on APOLLO Phase 3 Topline Results for Bitopertin in EPP · Quiver Quantitative
API: https://socialmediatrends-api.osmike.com/v1/trends/2787845